Centessa Pharmaceuticals (CNTA) Prepaid Assets (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported Prepaid Assets of $15.7 million for Q1 2026, up 15.1% year-over-year from $13.6 million in Q1 2025, and up 757.09% on a QoQ basis from $1.8 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) has 7 years of Prepaid Assets data on file, last reported at $15.7 million in Q1 2026.
- Quarterly Prepaid Assets rose 15.1% year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.7 million (up 15.1% YoY) and the FY2025 annual result came in at $1.8 million, down 82.54% from the prior year.
- Prepaid Assets rose to $15.7 million in Q1 2026 per CNTA's latest filing, from $1.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $22.7 million in Q3 2023 and bottomed at $1.1 million in Q1 2022.
- The 5-year median for Prepaid Assets is $3.3 million (2022), against an average of $7.6 million.
- The widest annual swing landed in 2023, when Prepaid Assets jumped 1658.77%; it then sank 89.89% in 2024.
- Tracing CNTA's Prepaid Assets over 5 years: stood at $3.3 million in 2022, then tumbled by 50.44% to $1.6 million in 2023, then jumped by 545.53% to $10.5 million in 2024, then tumbled by 82.54% to $1.8 million in 2025, then surged by 757.09% to $15.7 million in 2026.
- Per Business Quant, the three latest CNTA Prepaid Assets figures stand at $15.7 million (Q1 2026), $1.8 million (Q4 2025), and $2.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.66 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 2.76 Mn |
| Jun 30, 2025 | 8.94 Mn |
| Mar 31, 2025 | 13.61 Mn |
| Dec 31, 2024 | 10.46 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 18.76 Mn |
| Mar 31, 2024 | 1.80 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 22.65 Mn |
| Jun 30, 2023 | 3.87 Mn |
| Mar 31, 2023 | 17.77 Mn |
| Dec 31, 2022 | 3.27 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 993,000.00 |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 444,000.00 |
| Dec 31, 2020 | 6,000.00 |